08-06-2026 23:16 via drugs.com

Study Looks at Barriers to Initiation of Rotavirus Vaccine

MONDAY, June 8, 2026-- Risk factors for not initiating rotavirus vaccine (RVV) -- for which the first dose is recommended by a maximum age of 14 weeks, 6 days -- include extremely preterm birth and having no health insurance, according to a study...
Read more »

Pharmaceutical Industry news



FDA Approves Xocova for COVID-19 Postexposure Prophylaxis
ADA: GLP-1 Receptor Agonist Use Beneficial in Adults With Obesity, Autoimmune Disease
ERA: Dihydropyridine Calcium-Channel-Blockers Tied to Higher Risk for Kidney Disease Progression in T2D
EULAR: Obexelimab Can Lower Risk for Disease Flare in Active IgG4-Related Disease
Complications Similar for Decompression With or Without Duraplasty for Chiari I and Syringomyelia
Oral Drug Combo Effective for Older Patients With Acute Myeloid Leukemia
Prayer at Primary Care Appointments Tied to Reductions in Pain, Anxiety
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2
ASCO: Tile-Based Radiation Beneficial for Newly Resectable Brain Mets
ASCO: Apalutamide + ADT Beneficial in High-Risk Localized Prostate Cancer
Wearable Ultrasound Patch Provides Continuous Fetal Monitoring
Cardiometabolic Genetics Linked to Cognitive-Related Outcomes
Dose Reduction of Biologics Effective, Safe for Psoriasis
High Prevalence of Clinical Obesity Seen Even With Normal BMI
Desktop versie